Valeant Pharmaceuticals reported $329M in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US USD 2.54B 364M
Aurora Cannabis Inc ACB:CN CAD -63864000 556.28M
Biogen BIIB:US USD 821M 53.8M
Canopy Growth Corp WEED:CN CAD -223691000 1.86B
Eli Lilly And LLY:US USD 2.04B 38.3M
Gilead Sciences GILD:US USD 2.52B 357M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Perrigo Ordinary Shares PRGO:US USD 96.7M 19.3M
Prestige Brands PBH:US USD 68.12M 1.52M
Revance Therapeutics RVNC:US USD -83993000 22.56M
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Valeant Pharmaceuticals VRX:CN USD 329M 92M